Metabolic syndrome (MS) represents worldwide public health issue characterized by a set of
cardiovascular risk factors including obesity, diabetes, dyslipidemia, hypertension, and …

The gut microbiota is a highly complex community which evolves and adapts to its host over
a lifetime. It has been described as a virtual organ owing to the myriad of functions it …

Excessive consumption of sweets is a risk factor for metabolic syndrome. A major chemical
feature of sweets is fructose. Despite strong ties between fructose and disease, the …

Objectives Decreased gut microbial gene richness (MGR) and compositional changes are
associated with adverse metabolism in overweight or moderate obesity, but lack …

The human intestine harbors a complex bacterial community called the gut microbiota. This
microbiota is specific to each individual despite the existence of several bacterial species …

Metabolic syndrome (MetS) consists of several medical conditions that collectively predict
the risk for cardiovascular disease better than the sum of individual conditions. The risk of …

The history of fecal microbiota transplantation (FMT) dates back even to ancient China.
Recently, scientific studies have been looking into FMT as a promising treatment of various …

High dietary fructose is a major contributor to insulin resistance and metabolic syndrome,
disturbing tissue and organ functions. Fructose is mainly absorbed into systemic circulation …

Metabolic syndrome (MetS) is a cluster of metabolic factors that increase the risk of
cardiovascular disease and type 2 diabetes mellitus (T2DM), which is in itself a major …

Fructose is one of the key dietary catalysts in the development of non-alcoholic fatty liver
disease (NAFLD). NAFLD comprises a complex disease spectrum, including steatosis (fatty …